CMTM6-Deficient Monocytes in ANCA-Associated Vasculitis Fail to Present the Immune Checkpoint PD-L1.

Frontiers in Immunology
Markus ZeisbrichReinhard E Voll

Abstract

ANCA-associated vasculitides (AAV) affect small- and medium-sized blood vessels. In active disease, vessel wall infiltrates are mainly composed of monocytes and macrophages. Immune checkpoint molecules are crucial for the maintenance of self-tolerance and the prevention of autoimmune diseases. After checkpoint inhibitor therapy, the development of autoimmune vasculitis has been observed. However, defects of immune checkpoint molecules in AAV patients have not been identified yet. Monocytes and monocyte-derived macrophages from AAV patients and healthy age-matched controls were tested for surface expression of immunoinhibitory checkpoint programmed cell death ligand-1 (PD-L1). Using in vitro co-culture approaches, the effect of monocyte PD-L1 expression on CD4+ T cell activation and proliferation was tested. Monocytes from AAV patients displayed lower PD-L1 expression and a defective PD-L1 presentation upon activation, an effect that was correlated with disease activity. Lower PD-L1 expression was due to increased lysosomal degradation of PD-L1 in AAV monocytes. We identified a reduced expression of CMTM6, a protein protecting PD-L1 from lysosomal breakdown, as the underlying molecular defect. PD-L1low AAV monocytes showed incre...Continue Reading

References

Jan 1, 1996·Journal of the American Society of Nephrology : JASN·H HallerF C Luft
Jun 12, 1999·Annals of the Rheumatic Diseases·A C Muller KoboldJ W Tervaert
Jul 31, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·N M IsbelR C Atkins
Jul 26, 2002·International Journal of Hematology·Kiyoko S Akagawa
Jan 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Julia A BrownGordon J Freeman
Jul 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Yvette E LatchmanArlene H Sharpe
Jul 12, 2005·Journal of Leukocyte Biology·Katja HattarUlf Sibelius
Apr 12, 2006·The Journal of Experimental Medicine·Mary E KeirArlene H Sharpe
Oct 11, 2008·Inflammation·Agneta WikmanStefan H Jacobson
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jun 5, 2012·The New England Journal of Medicine·Julie R BrahmerJon M Wigginton
Oct 10, 2012·Arthritis and Rheumatism·J C JennetteR A Watts
Jun 4, 2013·The New England Journal of Medicine·Omid HamidAntoni Ribas
Jul 9, 2014·Nature Reviews. Rheumatology·J Charles Jennette, Ronald J Falk
Dec 18, 2014·Clinical Journal of the American Society of Nephrology : CJASN·Lei ZhaoShane M Meehan
Feb 11, 2015·Annual Review of Physiology·Haoxing Xu, Dejian Ren
Dec 23, 2015·Results in Immunology·Giuseppe A RamirezAngelo A Manfredi
Apr 14, 2016·Rheumatology·Rob R H van den BromElisabeth Brouwer
Jan 14, 2017·Arthritis & Rheumatology·Maria E Suarez-AlmazorAdi Diab
Jan 25, 2017·Proceedings of the National Academy of Sciences of the United States of America·Hui ZhangCornelia M Weyand
Feb 12, 2017·Cancer Immunology, Immunotherapy : CII·Genevieve HartleySteven Dow
Aug 17, 2017·Nature·Riccardo MezzadraTon N M Schumacher
Aug 30, 2017·Journal of Leukocyte Biology·Cornelia M WeyandJörg J Goronzy
Nov 16, 2019·Journal for Immunotherapy of Cancer·Shuming ChenSuzanne L Topalian
Dec 5, 2019·Cancer Immunology, Immunotherapy : CII·Yeni RomeroAnna Zolkiewska
Dec 5, 2019·Frontiers in Immunology·Mitsuhiro AkiyamaCornelia M Weyand
Jul 28, 2020·Frontiers in Immunology·Vincent GiesAnne-Sophie Korganow
Jul 29, 2020·Journal for Immunotherapy of Cancer·Omar MamloukAla Abudayyeh
Sep 10, 2020·The Lancet Rheumatology·Romy HansildaarMichael T Nurmohamed
Nov 8, 2020·Cell Death & Disease·Qian GouYongzhong Hou

❮ Previous
Next ❯

Citations

Nov 17, 2021·Journal of Cancer Research and Clinical Oncology·Jie LiangBei Zhang

❮ Previous
Next ❯

Software Mentioned

RARENET
INTERREG
PERSONALIS

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.